JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koide, T.
Right arrow Articles by Hata, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koide, T.
Right arrow Articles by Hata, S.

Possible mechanisms of 15-hydroperoxyarachidonic acid-induced contraction of the canine basilar artery in vitro

T Koide, T Neichi, M Takato, H Matsushita, K Sugioka, M Nakano and S Hata

Pharmacological studies of the contraction induced by 15- hydroperoxyarachidonic acid (15-HPAA) were done in the isolated canine basilar artery. The maximal contractile force produced by 15-HPAA was 1.5 times that of serotonin and was equivalent to that of prostaglandin (PG) F2 alpha or PGA1. At concentrations in which reductions of [14C]-6- keto-PGF1 alpha (the breakdown product of PGI2) occurred, both 15-HPAA and tranylcypromine contracted the artery, whereas indomethacin consistently relaxed it. In the case of indomethacin, as the drug inhibited the synthesis of [14C]-PGE2, F2 alpha and thromboxane(TX) B2 (the breakdown product of TXA2) as well, it has been considered that the balances between PGI2 and other vasoconstrictive PGs or TX may regulate the tone of the artery. Furthermore, it was shown that 15-HPAA enhanced the synthesis of lipoxygenase products from [14C]arachidonic acid. Experiments were done, therefore, to know whether these enhanced lipoxygenase products participated in the manifestation of contraction induced by 15-HPAA or not. As a result, although indomethacin did not affect the contraction, significant reductions of the contraction were shown by eicosatetraynoic acid. These results suggest that enhanced synthesis of lipoxygenase products may be involved in eliciting contractile responses of 15-HPAA.

Volume 221, Issue 2, pp. 481-488, 05/01/1982
Copyright © 1982 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
P. Hardy, I. Dumont, M. Bhattacharya, X. Hou, P. Lachapelle, D. R. Varma, and S. Chemtob
Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy
Cardiovasc Res, August 18, 2000; 47(3): 489 - 509.
[Abstract] [Full Text] [PDF]

Home page
 VASC ENDOVASCULAR SURGHome page
H. Caner, S. Senaati, H. Bolay, K. Kilinc, and K. Benli
Protective Effect of the Iron Chelator Deferoxamine on Cerebral Vasospasm
Vascular and Endovascular Surgery, October 1, 1992; 26(8): 665 - 671.
[Abstract] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1982 by the American Society for Pharmacology and Experimental Therapeutics.